When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press release that the molecule had been “discovered by” its generative AI platform. Insilico leads a pack of companies using AI to rapidly come up with drug ideas humans might never think…
From $100 billion OpenAI commitments to $100,000 visa fees, this week showed just how much the tech landscape is shifting. On the latest episode of Equity, Anthony Ha and Max Zeff unpack the AI infrastructure gold rush and tech’s talent shuffle. Watch the full episode for more about: Equity is TechCrunch’s flagship podcast, produced by […]
Digital detoxing, the great lock-in — getting offline is going mainstream. I built a $100 million business on tangible marketing, so here’s how to reach prospects anywhere.
Julie Fussner, CEO of Culver’s, talks about the state of leadership today, what makes a brand truly great and how she’s managing growth while protecting the brand’s values and identity.